よむ、つかう、まなぶ。
【参考資料２－２】抗微生物薬適正使用の手引き 第四版（案）医科・入院編 (16 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_64503.html |
| 出典情報 | 厚生科学審議会 感染症部会（第99回 10／21）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
抗微生物薬適正使用の手引き
第四版
医科・入院編
1
3. 引用文献
2
3
4
1.
国際的に脅威となる感染症対策関係閣僚会議. 薬剤耐性(AMR)対策アクションプラン
2023-2027. 東京: 内閣官房; 2023.
5
6
2.
Ardal C, et al. International cooperation to improve access to and sustain effectiveness
of antimicrobials. Lancet. 2016. 387(10015):296-307.
7
8
9
3.
The Review on Antimicrobial Resistance. Tackling Drug-Resistant Infections Globally:
Final Report and Recommendations. https://amr-review.org/Publications.html. 最終閲覧
日 2023 年 3 月 24 日.
10
11
12
4.
Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial
resistance in 2019: a systematic analysis. Lancet. 2022. 12;399(10325):629-655. an
enormous, growing, and unevenly distributed threat to global
13
14
15
5.
GBD 2021 Antimicrobial Resistance Collaborators. Global burden of bacterial
antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050.
Lancet. 2024. 28;404(10459):1199-1226.
16
17
18
6.
Antimicrobial resistance: an enormous, growing, and unevenly distributed threat to
global health. https://www.thelancet.com/pb/assets/raw/Lancet/infographics/antibioticresistance-2024/antibiotic-resistance2024.pdf
19
20
7.
Arias CA, et al. Antibiotic-resistant bugs in the 21st century - a clinical super-challenge.
N Engl J Med. 2009. 360(5):439-443.
21
22
8.
全国抗菌薬販売量 2022 年調査データ. AMRCRC.
https://amrcrc.ncgm.go.jp/surveillance/020/file/Sales_2013-2022_1.pdf
23
24
9.
Fleming-Dutra KE, et al. Prevalence of Inappropriate Antibiotic Prescriptions Among US
Ambulatory Care Visits, 2010-2011. JAMA. 2016. 315(17):1864-1873.
25
26
27
28
10. Ono A, et al. Trends in healthcare visits and antimicrobial prescriptions for acute
infectious diarrhea in individuals aged 65 years or younger in Japan from 2013 to 2018
based on administrative claims database: a retrospective observational study, BMC
Infect Dis. 2021. 21(1):983.
29
30
31
11. Okubo Y, et al. National trends in appropriate antibiotics use among pediatric inpatients
with uncomplicated lower respiratory tract infections in Japan, J Infect Chemother. 2020.
26(11):1122-1128.
32
33
34
12. Jindai K, et al. Decline in oral antimicrobial prescription in the outpatient setting after
nationwide implementation of financial incentives and provider education: An interrupted
time-series analysis. Infect Control Hosp Epidemiol. 2023. 44(2):253-259.
35
36
37
38
13. Okubo Y, et al. Long-term Effectiveness of Financial Incentives for Not Prescribing
Unnecessary Antibiotics to Children with Acute Respiratory and Gastrointestinal
Infections: A Japan's Nationwide Quasi-Experimental Study. Clin Infect Dis. 2024.
ciae577.
39
40
14. JANIS 厚生労働省 院内感染対策サーベイランス事業
https://janis.mhlw.go.jp/about/index.html. 最終閲覧日 2023 年 6 月 19 日.
41
42
43
15. 日本環境感染学会 JHAIS 委員会
http://www.kankyokansen.org/modules/iinkai/index.php?content_id=4. 最終閲覧日 2023
年 6 月 19 日.
16
第四版
医科・入院編
1
3. 引用文献
2
3
4
1.
国際的に脅威となる感染症対策関係閣僚会議. 薬剤耐性(AMR)対策アクションプラン
2023-2027. 東京: 内閣官房; 2023.
5
6
2.
Ardal C, et al. International cooperation to improve access to and sustain effectiveness
of antimicrobials. Lancet. 2016. 387(10015):296-307.
7
8
9
3.
The Review on Antimicrobial Resistance. Tackling Drug-Resistant Infections Globally:
Final Report and Recommendations. https://amr-review.org/Publications.html. 最終閲覧
日 2023 年 3 月 24 日.
10
11
12
4.
Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial
resistance in 2019: a systematic analysis. Lancet. 2022. 12;399(10325):629-655. an
enormous, growing, and unevenly distributed threat to global
13
14
15
5.
GBD 2021 Antimicrobial Resistance Collaborators. Global burden of bacterial
antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050.
Lancet. 2024. 28;404(10459):1199-1226.
16
17
18
6.
Antimicrobial resistance: an enormous, growing, and unevenly distributed threat to
global health. https://www.thelancet.com/pb/assets/raw/Lancet/infographics/antibioticresistance-2024/antibiotic-resistance2024.pdf
19
20
7.
Arias CA, et al. Antibiotic-resistant bugs in the 21st century - a clinical super-challenge.
N Engl J Med. 2009. 360(5):439-443.
21
22
8.
全国抗菌薬販売量 2022 年調査データ. AMRCRC.
https://amrcrc.ncgm.go.jp/surveillance/020/file/Sales_2013-2022_1.pdf
23
24
9.
Fleming-Dutra KE, et al. Prevalence of Inappropriate Antibiotic Prescriptions Among US
Ambulatory Care Visits, 2010-2011. JAMA. 2016. 315(17):1864-1873.
25
26
27
28
10. Ono A, et al. Trends in healthcare visits and antimicrobial prescriptions for acute
infectious diarrhea in individuals aged 65 years or younger in Japan from 2013 to 2018
based on administrative claims database: a retrospective observational study, BMC
Infect Dis. 2021. 21(1):983.
29
30
31
11. Okubo Y, et al. National trends in appropriate antibiotics use among pediatric inpatients
with uncomplicated lower respiratory tract infections in Japan, J Infect Chemother. 2020.
26(11):1122-1128.
32
33
34
12. Jindai K, et al. Decline in oral antimicrobial prescription in the outpatient setting after
nationwide implementation of financial incentives and provider education: An interrupted
time-series analysis. Infect Control Hosp Epidemiol. 2023. 44(2):253-259.
35
36
37
38
13. Okubo Y, et al. Long-term Effectiveness of Financial Incentives for Not Prescribing
Unnecessary Antibiotics to Children with Acute Respiratory and Gastrointestinal
Infections: A Japan's Nationwide Quasi-Experimental Study. Clin Infect Dis. 2024.
ciae577.
39
40
14. JANIS 厚生労働省 院内感染対策サーベイランス事業
https://janis.mhlw.go.jp/about/index.html. 最終閲覧日 2023 年 6 月 19 日.
41
42
43
15. 日本環境感染学会 JHAIS 委員会
http://www.kankyokansen.org/modules/iinkai/index.php?content_id=4. 最終閲覧日 2023
年 6 月 19 日.
16